PT  - JOURNAL ARTICLE
AU  - San Emmanuel James
AU  - Sinaye Ngcapu
AU  - Aquillah M Kanzi
AU  - Houriiyah Tegally
AU  - Vagner Fonseca
AU  - Jennifer Giandhari
AU  - Eduan Wilkinson
AU  - Benjamin Chimukangara
AU  - Sureshnee Pillay
AU  - Lavanya Singh
AU  - Maryam Fish
AU  - Inbal Gazy
AU  - Khulekani Khanyile
AU  - Richard Lessells
AU  - Tulio de Oliveira
TI  - High Resolution analysis of Transmission Dynamics of Sars-Cov-2 in Two Major Hospital Outbreaks in South Africa Leveraging Intrahost Diversity
AID  - 10.1101/2020.11.15.20231993
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.15.20231993
4099  - http://medrxiv.org/content/early/2020/11/16/2020.11.15.20231993.short
4100  - http://medrxiv.org/content/early/2020/11/16/2020.11.15.20231993.full
AB  - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes acute, highly transmissible respiratory infection in both humans and wide range of animal species. Its rapid spread globally and devasting effects have resulted into a major public health emergency prompting the need for methodological interventions to understand and control its spread. In particular, The ability to effectively retrace its transmission pathways in outbreaks remains a major challenge. This is further exacerbated by our limited understanding of its underlying evolutionary mechanism. Using NGS whole-genome data, we determined whether inter- and intra-host diversity coupled with bottleneck analysis can retrace the pathway of viral transmission in two epidemiologically well characterised nosocomial outbreaks in healthcare settings supported by phylogenetic analysis. Additionally, we assessed the mutational landscape, selection pressure and diversity of the identified variants. Our findings showed evidence of intrahost variant transmission and evolution of SARS-CoV-2 after infection These observations were consistent with the results from the bottleneck analysis suggesting that certain intrahost variants in this study could have been transmitted to recipients. In both outbreaks, we observed iSNVs and SNVs shared by putative source-recipients pairs. Majority of the observed iSNVs were positioned in the S and ORF1ab region. AG, CT and TC nucleotide changes were enriched across SARS-COV-2 genome. Moreover, SARS-COV-2 genome had limited diversity in some loci while being highly conserved in others. Overall, Our findings show that the synergistic effect of combining withinhost diversity and bottleneck estimations greatly enhances resolution of transmission events in Sars-Cov-2 outbreaks. They also provide insight into the genome diversity suggesting purifying selection may be involved in the transmission. Together these results will help in developing strategies to elucidate transmission events and curtail the spread of Sars-Cov-2Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by The South African Medical Research Council (SAMRC), MRC SHIP and the Department of Science and Innovation (DSI) of South Africa. KRISP is funded by a core award of the South African Technology Innovation Agency (TIA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project was approved by University of KwaZulu-Natal Biomedical Research Ethics Committee. Protocol reference number: BREC/00001195/2020. Project title: COVID-19 transmission and natural history in KwaZulu-Natal, South Africa: Epidemiological Investigation to Guide Prevention and Clinical Care.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is public available at GISAID and short reads at the Short Read Archive of NCBI. https://www.gisaid.org https://www.krisp.org.za/ngs-sa/ngs-sa_open_science_and_sharing_data_rapidly_but_believe_that_research_should_be_fair/